Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STEPAN CO Regulatory Filings 2023

Apr 14, 2023

32175_rns_2023-04-14_b46e2b15-1129-43d1-bc44-472df406ff92.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 13, 2023

STEPAN COMPANY

(Exact name of Registrant as Specified in Its Charter)

Delaware 1-4462 36-1823834
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
1101 Skokie Boulevard Suite 500
Northbrook , Illinois 60062
(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: 847 446-7500

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1 par value SCL The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of June 30, 2023, Arthur W. Mergner, Executive Vice President, Supply Chain, will retire from Stepan Company (the “Company”) after more than 34 years of service to the Company.

Effective as of May 1, 2023, Robert Haire will succeed Mr. Mergner in the position of Executive Vice President, Supply Chain of the Company. Mr. Mergner will assist in the transition until his retirement. Mr. Haire brings over 28 years of industrial operational experience to the Company. Since 2016 he has served as Senior Vice President Operations, Performance Chemicals at Ingevity Corporation, which manufactures performance chemicals and performance materials for use in markets such as adhesives, agrochemicals, bioplastics, coatings, and others. He also previously held operational roles at FMC Corporation and Chemtura Corporation and served as an officer in the U.S. Navy. Mr. Haire holds a BS in Chemical/Bioresource Engineering from Rutgers University and an MBA from Cornell University.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STEPAN COMPANY — /s/ David G. Kabbes
David G. Kabbes Vice President, General Counsel and Secretary